- Home
- CMPX vs ICG Comparison
CMPX vs ICG Comparison
Compare CMPX & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ICG
- Stock Information
- Founded
- CMPX 2014
- ICG 2017
- Country
- CMPX United States
- ICG China
- Employees
- CMPX N/A
- ICG N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ICG Semiconductors
- Sector
- CMPX Health Care
- ICG Technology
- Exchange
- CMPX Nasdaq
- ICG Nasdaq
- Market Cap
- CMPX 229.5M
- ICG 230.3M
- IPO Year
- CMPX N/A
- ICG 2023
- Fundamental
- Price
- CMPX $1.82
- ICG $2.32
- Analyst Decision
- CMPX Strong Buy
- ICG Strong Buy
- Analyst Count
- CMPX 8
- ICG 2
- Target Price
- CMPX $13.13
- ICG $9.50
- AVG Volume (30 Days)
- CMPX 762.7K
- ICG 24.0K
- Earning Date
- CMPX 05-08-2025
- ICG 05-19-2025
- Dividend Yield
- CMPX N/A
- ICG N/A
- EPS Growth
- CMPX N/A
- ICG N/A
- EPS
- CMPX N/A
- ICG 0.12
- Revenue
- CMPX $850,000.00
- ICG $38,602,978.00
- Revenue This Year
- CMPX $47.65
- ICG N/A
- Revenue Next Year
- CMPX $2,622.79
- ICG $147.04
- P/E Ratio
- CMPX N/A
- ICG $20.74
- Revenue Growth
- CMPX N/A
- ICG 242.68
- 52 Week Low
- CMPX $0.77
- ICG $1.40
- 52 Week High
- CMPX $4.08
- ICG $12.04
- Technical
- Relative Strength Index (RSI)
- CMPX 46.49
- ICG 52.60
- Support Level
- CMPX $1.79
- ICG $2.01
- Resistance Level
- CMPX $1.95
- ICG $2.56
- Average True Range (ATR)
- CMPX 0.14
- ICG 0.21
- MACD
- CMPX 0.01
- ICG 0.12
- Stochastic Oscillator
- CMPX 29.52
- ICG 78.32
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments.